July 11, 2016Open Access
View Full PaperEfficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
Key Points
Key points are not available for this paper at this time.
Abstract
Crisaborole demonstrated a favorable safety profile and improvement in all measures of efficacy, including overall disease severity, pruritus, and other signs of AD.
Cite This Study
Paller et al. (Mon,) studied this question.